Lynx Financial connects life science innovators across China, the U.S., and Europe with capital and strategic partners, leveraging a team of physicians, scientists, and investors to accelerate medical technologies to patients globally.
Preferred startup development maturity for initial funding deployment.
Cross-border healthcare innovation (pharma, diagnostics, medical devices) with a focus on oncology, cardiovascular, rare diseases, pre-operative cancer diagnostics, medical devices (e.g., valves, implants), and global R&D acceleration.
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
